RB-ILD is a dubious disease in the field of infectious respiratory digestive and endocrine disorders, clinical performance is complex and often involves multi-system congestion. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of this disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological biopsy.
The platform can assist in connecting teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of respiratory branch inflammation associated with interstitial lung disease RB-ILD require individualized development, typically including multidimensional management of drug therapy, rehabilitation interventions, regular follow-up, etc. In recent years, with the development of targeted therapy, immune regulation therapy, and precision medicine, many previously difficult-to-treat infectious respiratory digestive and endocrine diseases have been significantly improved.
Treatment requires close monitoring of therapeutic efficacy and adverse reactions and timely adjustment according to changes in conditions. Multidisciplinary collaboration programs MDT are especially important for the integrated management of interstitial lung disease RB-ILD associated with respiratory branch inflammation. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of infectious respiratory digestive and endocrine secretion to provide the following services to patients: 1.
Remote pre-diagnosis: Pre-examination of medical records, clear diagnostic directions and medical advice by the team of experts; 2. Interviews in China: Arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3. Full-service: One-stop services: Medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: Establishment of a chronic disease management file, continuous monitoring of changes in disease and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.